Company announcementCompany-reported
What was reported
Mountain View, Calif. – July 28, 2026 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today provided an update on the U.S. Food and Drug Administration review of the Company’s Premarket Approval Panel Track Supplement seeking to expand the labeled indication for the RNS® System to include patients with antiseizure medication-resistant idiopathic generalized epilepsy (IGE).U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 28, 2026 · Open the source ↗
What the evidence supports
NeuroPace furnished a press release to the SEC (Form 8-K, Item 7.01) about a company announcement. It shows what the company chose to disclose on that date.
What remains unknown
Claims in the release are the company's own and have not been independently verified. Furnishing a document to the SEC does not mean the SEC reviewed or endorsed it.
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Press release headlineNeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized EpilepsyU.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 28, 2026 · Open the source ↗
Press release lead paragraphMountain View, Calif. – July 28, 2026 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today provided an update on the U.S. Food and Drug Administration review of the Company’s Premarket Approval Panel Track Supplement seeking to expand the labeled indication for the RNS® System to include patients with antiseizure medication-resistant idiopathic generalized epilepsy (IGE).U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Jul 28, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:53 UTC
NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.